Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
NCT00322634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2012-09-19
Summary
The use of performance status and LDH in combination can predict patient survival more accurately than physician clinical impression or the patients' own feelings about their survival
Conditions
Sponsors & Collaborators
-
New Mexico Cancer Research Alliance
lead OTHER
Principal Investigators
-
Malcolm Purdy, MD · Hematology & Oncology Associates
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- United States
Study Locations
More Related Trials
-
Metformin in Non Small Cell Lung Cancer (NSCLC)
NCT02285855 ·Status: TERMINATED ·Phase: PHASE2
-
Clinico-biological Data Collection Study of Metastatic Lung Cancer
NCT04944030 ·Status: RECRUITING ·Phase: NA
-
Movement and Fitness Trackers in Determining Performance Status
NCT03971266 ·Status: TERMINATED ·Phase: NA
-
Physical Activity and Inactivity in Lung Cancer Survivors
NCT00582348 ·Status: COMPLETED
-
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
NCT02562027 ·Status: COMPLETED ·Phase: NA
-
Precision Performance Status Compared With ECOG Performance Status
NCT07082257 ·Status: ACTIVE_NOT_RECRUITING
-
Early Palliative Care in Metastatic Lung Cancer in Northern France
NCT02308865 ·Status: TERMINATED ·Phase: NA
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
Usefulness of Blood Biomarkers for Overall Survival in NSCLC
NCT01936571 ·Status: COMPLETED
-
Observational Study of Best Supportive Care With or Without Surgery, Chemo or Radiotherapy in Pts With Carcinoma of Lung
NCT00822016 ·Status: TERMINATED
-
A Prospective, Observational Trial on the Diagnostic and Prognostic of LM
NCT02607605 ·Status: UNKNOWN
-
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06443684 ·Status: RECRUITING
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
NCT02190864 ·Status: UNKNOWN
-
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
NCT00923884 ·Status: COMPLETED
-
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
NCT06358222 ·Status: RECRUITING
-
Biomarkers in Predicting Response in Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy
NCT01294280 ·Status: COMPLETED
-
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
NCT06842056 ·Status: NOT_YET_RECRUITING
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
NCT07243132 ·Status: RECRUITING
-
Prospective Data Collection Initiative on Thoracic Malignancies
NCT06996249 ·Status: RECRUITING
-
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
NCT06086574 ·Status: RECRUITING
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
NCT06513663 ·Status: TERMINATED ·Phase: NA
-
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
NCT06410300 ·Status: RECRUITING